All articles by Robert Barrie
Robert Barrie is a trainee reporter for Medical Device Network, covering developments in the healthcare sector. Coming from a scientific and medical background, Robert has reported across various topics with expertise in neuroscience, genetics, and epidemiology. Previously, he worked on a freelance basis with New Scientist.
Novartis touts breast cancer win with “landmark” Kisqali results
Kisqali administered alongside hormone therapy reduced recurrence by 25% in patients with early-stage breast cancer.
Beta Bionics’ automated insulin delivery system picks up manufacturing partner
Insulin delivery devices are proliferating despite equitable insulin access being a challenge on a global scale.
Meningitis vaccine comes to the forefront with impressive study results
The affordable NmCV-5 vaccine is a step up from existing options that could contribute to WHO’s goal to defeat the epidemic by 2030.
FDA greenlights new long-term treatment option for opioid use disorder
Braeburn’s extended-release injection, Brixadi, joins a growing list of approvals this year to help tackle the opioid crisis.
ReNAgade Therapeutics enters RNA therapy arena with $300m
The new biotech company is assimilating a board of pharma veterans to make its RNA delivery platform the go-to solution.
Subscribe to our Newsletter
Get industry leading news, data and analysis delivered to your inbox
CureVac gets an early date in Covid-19 vaccine patent case with Pfizer/BioNTech
In the latest update of the ongoing Covid-19 mRNA vaccine dispute, CureVac has successfully moved the case to Virginia.
Treatment options for Crohn’s disease expand after Rinvoq approval
AbbVie’s blockbuster drug Rinvoq earned its seventh approval to become the first oral treatment for moderate to severe Crohn’s.
Sun rises on Lithuania’s life sciences industry
Psychedelic-producing yeast, tremor reduction balls, and leading gene-editing technology make for a bright life sciences sector in Lithuania.
EMA issues guidance amidst European medicine shortage
Whilst medicine shortages are a global health problem, European countries are being increasingly affected.
NICE recommends new digital therapies for patients with depression and anxiety
The digital therapies will give patients more options to access medical help.